Alison Blaus

Alison Blaus has a diverse work experience in the pharmaceutical and regulatory industries. Alison is currently the Vice President at Nkarta, Inc. Prior to that, they worked at Bristol Myers Squibb as a Director, serving as the Global Regulatory Strategy Leader for chimeric antigen receptor T cell therapy products. At Kite Pharma, they held roles as a Director and Associate Director in Regulatory Affairs. Alison also worked at Gilead Sciences as a Global Regulatory Product Lead and Associate Director. Before transitioning to the private sector, Alison worked at the FDA as a Senior Regulatory Health Project Manager. Alison began their career at Pfizer as a Regulatory Documents Author and at Johnson & Johnson as a Clinical Data Coordinator. Throughout their career, Alison has demonstrated expertise in regulatory strategy, global regulatory submissions, project management, and mentoring.

Alison Blaus completed their Bachelor of Science degree in Neuroscience at the University of Delaware from 1995 to 1999.